GB0000329D0 - Semiochemical capable of effecting gene expression - Google Patents

Semiochemical capable of effecting gene expression

Info

Publication number
GB0000329D0
GB0000329D0 GB0000329A GB0000329A GB0000329D0 GB 0000329 D0 GB0000329 D0 GB 0000329D0 GB 0000329 A GB0000329 A GB 0000329A GB 0000329 A GB0000329 A GB 0000329A GB 0000329 D0 GB0000329 D0 GB 0000329D0
Authority
GB
United Kingdom
Prior art keywords
semiochemical
gene expression
effecting gene
effecting
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0000329A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Priority to GB0000329A priority Critical patent/GB0000329D0/en
Publication of GB0000329D0 publication Critical patent/GB0000329D0/en
Priority to JP2001542753A priority patent/JP2003515613A/en
Priority to DE60018203T priority patent/DE60018203T2/en
Priority to US10/149,200 priority patent/US6890525B2/en
Priority to ES00985527T priority patent/ES2236021T3/en
Priority to CA002388964A priority patent/CA2388964C/en
Priority to PCT/GB2000/004733 priority patent/WO2001041568A2/en
Priority to AT00985527T priority patent/ATE289164T1/en
Priority to PT00985527T priority patent/PT1235483E/en
Priority to EP00985527A priority patent/EP1235483B1/en
Priority to AU21940/01A priority patent/AU783788B2/en
Priority to US10/996,741 priority patent/US7820153B2/en
Priority to US12/781,947 priority patent/US8221736B2/en
Ceased legal-status Critical Current

Links

GB0000329A 1999-12-10 2000-01-07 Semiochemical capable of effecting gene expression Ceased GB0000329D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0000329A GB0000329D0 (en) 2000-01-07 2000-01-07 Semiochemical capable of effecting gene expression
AU21940/01A AU783788B2 (en) 1999-12-10 2000-12-11 Semiochemical
PCT/GB2000/004733 WO2001041568A2 (en) 1999-12-10 2000-12-11 Cis-jasmone as semiochemical
DE60018203T DE60018203T2 (en) 1999-12-10 2000-12-11 CIS-JASMON AS SEMIO-CHEMICAL
US10/149,200 US6890525B2 (en) 1999-12-10 2000-12-11 Semiochemical
ES00985527T ES2236021T3 (en) 1999-12-10 2000-12-11 CIS-JASMONA AS A SEMIOCHEMICAL SUBSTANCE.
CA002388964A CA2388964C (en) 1999-12-10 2000-12-11 Cis-jasmone as semiochemical
JP2001542753A JP2003515613A (en) 1999-12-10 2000-12-11 Information substance
AT00985527T ATE289164T1 (en) 1999-12-10 2000-12-11 CIS-JASMONE AS A SEMIO-CHEMICAL
PT00985527T PT1235483E (en) 1999-12-10 2000-12-11 CIS-JASMONA WITH SEMIO-CHEMICAL
EP00985527A EP1235483B1 (en) 1999-12-10 2000-12-11 Cis-jasmone as semiochemical
US10/996,741 US7820153B2 (en) 1999-12-10 2004-11-24 Semiochemical
US12/781,947 US8221736B2 (en) 1999-12-10 2010-05-18 Semiochemical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0000329A GB0000329D0 (en) 2000-01-07 2000-01-07 Semiochemical capable of effecting gene expression

Publications (1)

Publication Number Publication Date
GB0000329D0 true GB0000329D0 (en) 2000-03-01

Family

ID=9883340

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0000329A Ceased GB0000329D0 (en) 1999-12-10 2000-01-07 Semiochemical capable of effecting gene expression

Country Status (1)

Country Link
GB (1) GB0000329D0 (en)

Similar Documents

Publication Publication Date Title
AU2001291859A1 (en) Use of copolycarbonates
AU2001229712A1 (en) Reduction of hair growth
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2347002A (en) Modulation of the transcription of pro-inflammatory gene products
AU2002231206A1 (en) Treatment of depression
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2001257220A1 (en) Antisense modulation of inhibitor of dna binding-1 expression
AU2002318139A1 (en) Antisense modulation of src-c expression
AU2002222618A1 (en) Method of analyzing gene expression
AU2001245741A1 (en) Antisense inhibition of adam10 expression
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AUPQ885500A0 (en) Enhancement of products
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
GB0205640D0 (en) Decoration of conservatives
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2002219992A1 (en) Targeted regulation of gene expression
AU2001268322A1 (en) Antisense modulation of c/ebp alpha expression
GB0000329D0 (en) Semiochemical capable of effecting gene expression
AU2002245089A1 (en) Antisense modulation of cytohesin-1 expression
GB9929309D0 (en) Semiochemical capable of effecting gene expression
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2001281371A1 (en) Inhibition of gene expression using polynucleotide analogues
AUPR282501A0 (en) Expression facilitating nucleotides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)